NM_000257.4:c.427C>G
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PS1_ModeratePM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000257.4(MYH7):c.427C>G(p.Arg143Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R143Q) has been classified as Pathogenic.
Frequency
Consequence
NM_000257.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy Pathogenic:1
This variant disrupts the p.Arg143 amino acid residue in MYH7. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15358028, 15563892, 21252143, 22765922, 24093860). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYH7 protein function. This missense change has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 12820698, 22429680). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 143 of the MYH7 protein (p.Arg143Gly). -
Cardiovascular phenotype Pathogenic:1
The p.R143G variant (also known as c.427C>G), located in coding exon 3 of the MYH7 gene, results from a C to G substitution at nucleotide position 427. The arginine at codon 143 is replaced by glycine, an amino acid with dissimilar properties. This alteration has been reported in association with hypertrophic cardiomyopathy (HCM) (Mohiddin SA et al. Genet. Test., 2003;7:21-7; Santos S et al. BMC Med. Genet., 2012 Mar;13:17). Two other variants at the same codon, p.R143W (c.427C>G) and p.R143Q (cc.428G>A), have been detected in HCM cohorts (Song L et al. Clin. Chim. Acta. 2005;351:209-16; Mohiddin SA et al. Genet. Test., 2003;7:21-7). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Hypertrophic cardiomyopathy 1 Pathogenic:1
The variant NM_000257.4:c.427C>G (chr14:23432714) in MYH7 was detected in 5 heterozygotes out of 58K WGS Icelanders (MAF= 0,004%). Following imputation in a set of 166K Icelanders (10 imputed heterozygotes) we observed an association with hypertrophic cardiomyopathy using 640 cases and 355022 controls (OR= 48.2, P= 2.2e-02). This variant has not been reported in ClinVar previously. Based on ACMG criteria (PS4, PM1, PM5, PP3) this variant classifies as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at